Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21629990 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Biological: cetuximab;   Biological: bevacizumab;   Drug: gemcitabine

Indicates status has not been verified in more than two years